LinkBIO Co., Ltd
Aptamers Discovery to Promote Therapeutics and Diagnostics
Aptamers Discovery to Promote Therapeutics and Diagnostics
LinkBIO Co., Ltd, a biotechnology startup, is focused on leveraging MACE-SELEX technologies from The University of Tokyo to accelerate the development of innovative drugs and diagnostics. Founded in 2020 and headquartered in Japan, the company's mission is underlined by its slogan, "Aptamers Discovery to Promote Therapeutics and Diagnostics." Having secured a Seed Round investment in October 2020 from Samurai Incubate, LinkBIO is poised to make significant strides in the biotechnology and pharmaceutical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
19 Oct 2020 |
No recent news or press coverage available for LinkBIO Co., Ltd.
We care about your data, and we'd love to use cookies make your experience better.
